Egyptian Liver Journal

Table 4 Multivariate analysis of the effect of simvastatin in improving the survival

From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

	Multivariate
	OR (95% CI)	p-value
Encephalopathy	0.725 (0.352–1.652)	0.998
Survival	0.136 (0.020–0.916)	0.040*
Myalgia	5.812 (0.658–51.361)	0.113
Child score	4.419 (0.874–22.341)	0.072

Back to article page